Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Total
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Balance at beginning of period at Dec. 31, 2018 $ 22,306 $ 719 $ 24,281 $ (2,694)
Balance at beginning of period (in shares) at Dec. 31, 2018   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated (13,739)     (13,739)
Balance at end of period at Mar. 31, 2019 8,567 $ 719 24,281 (16,433)
Balance at end of period (in shares) at Mar. 31, 2019   7,187,500    
Balance at beginning of period at Dec. 31, 2018 22,306 $ 719 24,281 (2,694)
Balance at beginning of period (in shares) at Dec. 31, 2018   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Remeasurement of ordinary shares subject to possible redemption (30,100,000)      
Net income (loss), as restated 5,094,479      
Balance at end of period at Sep. 30, 2019 (20,897,805) $ 719   (20,898,524)
Balance at end of period (in shares) at Sep. 30, 2019   7,187,500    
Balance at beginning of period at Mar. 31, 2019 8,567 $ 719 24,281 (16,433)
Balance at beginning of period (in shares) at Mar. 31, 2019   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Proceeds from sale of private warrants in excess of fair value, as restated 775,000   775,000  
Remeasurement of ordinary shares subject to possible redemption (26,789,590)   $ (799,281) (25,990,309)
Net income (loss), as restated 4,609,364     4,609,364
Balance at end of period at Jun. 30, 2019 (21,396,659) $ 719   (21,397,378)
Balance at end of period (in shares) at Jun. 30, 2019   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated 498,854     498,854
Balance at end of period at Sep. 30, 2019 (20,897,805) $ 719   (20,898,524)
Balance at end of period (in shares) at Sep. 30, 2019   7,187,500    
Balance at beginning of period at Dec. 31, 2019 (21,893,764) $ 719   (21,894,483)
Balance at beginning of period (in shares) at Dec. 31, 2019   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated 6,725,368     6,725,368
Balance at end of period at Mar. 31, 2020 (15,168,396) $ 719   (15,169,115)
Balance at end of period (in shares) at Mar. 31, 2020   7,187,500    
Balance at beginning of period at Dec. 31, 2019 (21,893,764) $ 719   (21,894,483)
Balance at beginning of period (in shares) at Dec. 31, 2019   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated (2,398,841)      
Balance at end of period at Sep. 30, 2020 (24,292,605) $ 719   (24,293,324)
Balance at end of period (in shares) at Sep. 30, 2020   7,187,500    
Balance at beginning of period at Mar. 31, 2020 (15,168,396) $ 719   (15,169,115)
Balance at beginning of period (in shares) at Mar. 31, 2020   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated (7,046,470)     (7,046,470)
Balance at end of period at Jun. 30, 2020 (22,214,866) $ 719   (22,215,585)
Balance at end of period (in shares) at Jun. 30, 2020   7,187,500    
Increase (Decrease) in Stockholders' Equity        
Net income (loss), as restated (2,077,739)     (2,077,739)
Balance at end of period at Sep. 30, 2020 $ (24,292,605) $ 719   $ (24,293,324)
Balance at end of period (in shares) at Sep. 30, 2020   7,187,500